US Patent Issued to The Brigham and Women's Hospital, Beth Israel Deaconess Medical Center on Sept. 30 for "Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,410, issued on Sept. 30, was assigned to The Brigham and Women's Hospital Inc. (Boston) and Beth Israel Deaconess Medical Center Inc. (Boston).

"Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy" was invented by Mark Feinberg (Newton, Mass.) and Santosh A. Khedkar (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compositions and methods for inhibiting Kruppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy."

The patent was filed on Jan. 28, 2022, under Application No. 17/587,304.

*For further information, including i...